FDA Approves Meloxicam Injection for Moderate to Severe Pain in Adults

The FDA has approved Xifyrm for use in adults for the management of moderate to severe pain, alone or in ...

JUNE 12, 2025

Nonopioid Bupivacaine-Meloxicam Combo Gets Expanded Indications

Heron Therapeutics announced that the FDA approved a supplemental New Drug Application sNDA for its ...

FEBRUARY 17, 2022

Bupivacaine-Meloxicam Combination Provides Better Opioid–Sparing Pain Control Than Bupivacaine HCl Alone

A new bupivacaine-meloxicam combo showed significant reduction in both pain and opioid use in older adults ...

DECEMBER 6, 2021

Nonopioid Multimodal Pain Protocol Shown Effective After Meniscus Surgery

A novel multimodal pain management protocol is effective at providing immediate pain relief for patients undergoing ...

JULY 16, 2021

FDA Approves Nonopioid Extended-Release Solution for Post-op Analgesia

The FDA approved an extended-release solution of bupivacaine and meloxicam to be used in adults for postoperative ...

MAY 13, 2021

Managing Surgical Pain With the First and Only Once-Daily IV Analgesic: Pre- and Postoperative Use of a Nonopioid Alternative

Surgical pain is prevalent and undermanaged despite advances in surgical techniques. This monograph details an IV ...

NOVEMBER 4, 2020

FDA Approves Once-Daily IV NSAID for Moderate to Severe Pain

The FDA approved the New Drug Application for a meloxicam injection, which is indicated for managing moderate to ...

MARCH 13, 2020

FDA Accepts NDA Resubmission for Bupivacaine-Meloxicam Combination for Postoperative Pain

The FDA accepted a New Drug Application resubmission for HTX-011, an investigational agent for the management of ...

NOVEMBER 4, 2019